ZENO Trademark

Trademark Overview

On Thursday, May 3, 2018, a trademark application was filed for ZENO with the United States Patent and Trademark Office. The USPTO has given the ZENO trademark a serial number of 87906355. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by Zeno Pharma, LLC. The ZENO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; pharmaceutical research and development
zeno

General Information

Serial Number87906355
Word MarkZENO
Filing DateThursday, May 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements

Goods and ServicesDrug discovery services; pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 14, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZeno Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameZeno Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 17, 2019EXTENSION 1 GRANTED
Tuesday, December 17, 2019EXTENSION 1 FILED
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Saturday, November 2, 2019CORRECTED NOA E-MAILED
Friday, November 1, 2019DIVISIONAL PROCESSING COMPLETE
Thursday, October 17, 2019DIVISIONAL REQUEST RECEIVED
Thursday, October 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 17, 2019TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 23, 2019ASSIGNED TO LIE
Saturday, March 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2018NON-FINAL ACTION WRITTEN
Friday, August 24, 2018ASSIGNED TO EXAMINER
Monday, May 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 7, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

zeno research development pharmaceutical services discovery drug